Concepedia

Herbert Birnboeck

HB

12

Publications

964

Citations

12

H-Index

1996

Active since

Affiliations

Roche (Switzerland)(Current)

Roche Pharma AG (Germany)

Bristol-Myers Squibb (United States)

Sanofi (United States)

UCB Pharma (Belgium)

Herbert Birnboeck is an author at Roche (Switzerland) specializing in medicine, immunology, and pharmacology.

Top concepts

Publications per year

1996–2017

12

Publications

12

Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects

Cornelia Weber, Rita Schmitt, Herbert Birnboeck et al. · Clinical Pharmacology & Therapeutics · 1996 · 204 citations

Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models

Brian Higgins, Kenneth Kolinsky, Melissa Smith et al. · Anti-Cancer Drugs · 2004 · 152 citations

, , +12

Low immunogenicity of tocilizumab in patients with rheumatoid arthritis

Gerd R Burmester, Ernest Choy, Alan Kivitz et al. · Annals of the Rheumatic Diseases · 2016 · 101 citations · Full text

Multiple‐Dose Pharmacokinetics, Safety, and Tolerability of Bosentan, an Endothelin Receptor Antagonist, in Healthy Male Volunteers

Cornelia Weber, Rita Schmitt, Herbert Birnboeck et al. · The Journal of Clinical Pharmacology · 1999 · 92 citations

, , +14

Effect of the Endothelin‐Receptor Antagonist Bosentan on the Pharmacokinetics and Pharmacodynamics of Warfarin

Cornelia Weber, Ludger Banken, Herbert Birnboeck et al. · The Journal of Clinical Pharmacology · 1999 · 80 citations

Rows per page

1–5 of 12